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Introduction 
In chronic kidney disease (CKD), uraemic symptoms and the presence of inflammation can 
contribute to poor dietary intake and an increase in metabolic stress1. Collectively, this leads 
to a reduction in body protein synthesis, hence a decline in nutritional status, herein termed 
malnutrition2. Malnutrition in CKD is an independent predictor of morbidity and mortality3, 4.
Malnutrition remains a critical risk factor for poor outcome in CKD5 despite the increasing BMI 
of the Australian population6. Prospective data suggests a high BMI may be predictive of 
reduced morbidity and mortality compared to a lower BMI in haemodialysis populations7.
Recent evidence indicates weight loss and reduction in appetite are key precipitating factors 
for malnutrition and independent predictors of poor outcome for CKD patients8,9. Therefore, 
despite the increase in overweight and obesity in the population, there is sufficient evidence 
supporting the need for a consistent method of nutrition assessment to capture symptoms 
leading to unintentional weight loss, wasting, and the diagnosis of malnutrition. 
 
Assessment of malnutrition is an important component of dietetic practice and improves the 
dietitians ability to prioritise intervention to those most at risk.  A clinically useful marker 
should be able to identify malnutrition, assess the resulting risk of morbidity and mortality and 
also evaluate the response to nutrition intervention 10. Interpretation of methods to assess 
nutrition status in CKD including anthropometric (e.g. weight change, skin-fold assessments) 
and biochemical (e.g. serum albumin) can have limitations due to the nature of CKD10. For 
example, weight change may be due to fluid shifts and hypoalbuminemia due to acute 
inflammation therefore, may not be true markers of nutrition status.  Therefore current 
evidence-based practice guidelines for nutrition management in CKD guidelines recommend 
use of a panel of parameters in clinical practice, including the clinical tool, Subjective Global 
Assessment (SGA)11-13.
SGA provides a comprehensive appraisal of nutrition status considering a medical and 
physical assessment (combining parameters of weight change, dietary intake, symptoms of 
gastro-intestinal distress and a physical examination) and classify’s nutrition status as well-
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nourished (A), mild to moderately malnourished (B), or severely malnourished (C)14.
Therefore, SGA is recommended to assist in determining who to target for nutrition support, 
as it represents quick, cost-effective, multi-disciplinary assessment, not influenced by the 
metabolic anomalies of CKD15.
The prevalence of malnutrition in CKD as assessed by SGA has remained consistent over 
past 20 years.  Since SGA was first introduced in CKD in 1987, international prevalence of 
malnutrition ranges around 30-40% (Table 1) and studies conducted over the last 5 years in 
Australia indicate a rate from 20 to 48%16-20.
Rating nutrition status on three broad categories has brought recent criticism of SGA’s ability 
to measure the degree of malnutrition20 and identify small, yet clinically significant changes in 
nutrition status21. A number of modified and/or scored SGA-based assessment tools have 
appeared in the CKD literature, creating confusion about which is the most appropriate tool to 
use (Table 2)15.
Given the number of SGA-based tools available for use in CKD, it is critical to evaluate their 
validity and reliability15, to build an evidence base and promote consistency in nutrition 
assessment in clinical practice. There are a number of types of validity and reliability outlined 
in Table 3.  The strength and applicability of validation studies depends on the study design, 
sample selection, administration and reference parameters or outcome measures used22.
This review aims to critically evaluate studies investigating the SGA and associated tools to 
provide insight into informing best practice and consistency in methods used for nutrition 
assessment in CKD. 
Methods 
A literature search was conducted to answer the research question: ‘What SGA-based tools 
were available to assess the nutrition status of CKD patients?’  The articles were then 
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evaluated to answer, ‘To what extent has this particular tool been tested for validity/reliability 
in CKD patients?’  The review will include nutrition assessment at all stages of CKD. 
 
Inclusion Criteria:  Articles introducing, validating or assessing the feasibility of a SGA-
based assessment tool in CKD, where screening or assessment tools were completed by 
dietitian, nurse or trained physician were included.  Particular emphasis was placed on 
articles where the assessment method is measured against a reference standard or 
evaluated against clinical follow-up.  Original research articles not fulfilling the criteria of a 
validation study were only evaluated for prevalence of malnutrition (Table 1).   
 
Search Strategy:  Cochrane, MEDLINE and CINAHL databases using the MeSH terms 
“Nutrition assessment”, “Malnutrition” and “Chronic Kidney Disease” OR “Kidney Failure”.  In 
addition the subject “Subjective Global Assessment” or “SGA” was used in combination with 
the MeSH terms.  Limits of “Valid*”; “Reliab*” used where necessary.  
 
Evaluation of Methodological Quality:  Each study was assessed for quality using criteria 
guided by Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS)23and Jones 
(2004)24 The studies were evaluated against the NHMRC draft levels of evidence (Table 3)25.
Tools are assigned a level of diagnostic evidence depending on the study design and 
reference standards for clinical and/or criterion validity.  Tools indicating predictive validity are 
assigned level II prognostic evidence if the tool had displayed sufficient diagnostic evidence 
(Table 3). 
 
Results   
In the CKD literature, at least eight different SGA-based tools were evident11, 18, 21, 26-30. Table 
4 is a summary of the SGA-derived tools, validity, reliability, design comments and NHMRC 
levels of evidence for the tools featured in this article. Reference standards are used to test 
clinical, predictive and criterion validity18-21, 26, 28, 31-34 and multiple raters and internal 
consistency checks to investigate reliability18, 20, 27.
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Validity 
Original SGA: The original SGA was first investigated in a validation study in haemodialysis 
(HD) and peritoneal dialysis (PD) patients in 199326, where SGA appeared to display clinical 
validity with albumin, bioimpedance (BIA) phase angle, mid arm muscle circumference 
(MAMC), percent body fat (%BF) and normalised protein catabolic rate (nPCR) with multiple 
regression analysis confirming the strong relationship between SGA and the combined 
objective measures (multiple r = 0.77).  Lawson et al (1999), in a 12-month follow-up study 
further investigated the predictive validity of the SGA in HD patients, determining SGA B or C 
rating results in significantly increased mortality, likelihood of acute hospitalisation, and 
depleted FFM (as measured by BIA)19.
In an investigation by Cooper et al (2000), Nitrogen Index (measured total body nitrogen 
compared to sex- age- height matched general population), was significantly lower in patients 
rated SGA  B and C compared to A 20. However, when criterion validity was assessed using 
<85% of expected Nitrogen Index (NI) as a gold-standard for malnutrition, SGA could not 
confidently differentiate between well-nourished, malnourished and degree of malnutrition (B 
and C)20. According to this criterion, 29% of the subjects were malnourished (NI <85% of 
predicted), compared to >40% by the SGA20. However, as malnutrition is a progressive 
wasting disease, there is a risk with using cross-sectional body composition measures to 
“diagnose” malnutrition.  Significant wasting by an overweight patient (BMI > 25kg/m2), and/or 
moderate weight loss with significant uraemic symptoms, anorexia and lethargy contributing 
to a legitimate SGA B rating, is unlikely to register under the reference cut-off of a low NI (i.e. 
<85% of predicted). 
 
Retrospective modified-SGA: Pifer et al (1999) reported the mSGA predicted 25% 
increased mortality for SGA C, compared to SGA A and B at 6 months31. In this study, there 
was a greater proportion of “severely malnourished” (11%) than “moderately malnourished” 
(7%)31 patients.    
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7-point SGA: The introduction of the 7-point SGA, revealed predictive validity for 12-month 
survival, indicating a reduction in one category of the 7-point scale equating to a 25% 
increased relative risk of death33 determined by Cox proportional hazard model.  In a more 
recent paper, Jones et al (2004) investigated the criterion validity of both the original SGA, 
and the 7-point SGA by a “composite nutrition score” (higher score, lower nutrition status; 
derived from parameters including BMI, albumin and anthropometry)32. The mean difference 
in composite scores of SGA A vs. B and each of the categories 3 to 7 was statistically 
significant (using correlation analysis), however, both tools had considerable overlap of 
composite scores between categories, particularly for 7-point SGA33.
Scored-SGA: In its initial investigation, the Dialysis Malnutrition Score (DMS) significantly 
correlated with a number of nutrition-related biochemical parameters21. In a 12-month 
prospective study, the DMS was included in an investigation of the Malnutrition Inflammation 
Score (MIS) and SGA and were compared with a range of biochemical indices and 
morbidity/mortality outcomes.  The MIS correlated the most significantly with 12-month 
survival and hospitalisation, creatinine level, hematocrit, and CRP, which is not surprising 
considering it contains biochemical parameters related to iron and inflammatory status (TIBC, 
Alb) 28. A more recent paper of 378 HD subjects with a similar study design confirmed the 
predictive validity of MIS >8 to predict poor clinical outcome (mortality and hospitalisation)34.
The Patient-Generated SGA (PG-SGA), previously validated in oncology patients, was 
published in HD by Desbrow et al (2005)18 investigating criterion and clinical validity.  Criterion 
validity, using the original SGA as the gold-standard, was demonstrated by a significant 
difference in PG-SGA scores between well-nourished (A, median (range) = 2 (0-13) and 
malnourished (B, median score = 16(7-26))18. Clinical validity to serum albumin was 
demonstrated by a significant correlation with the PG-SGA score (Table 4).   
 
Reliability  
The initial reliability study for the original SGA in surgical patients revealed good inter-rater 
reliability (kappa = 0.78)14. In CKD, agreements between the ratings of the SGA categories 
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appear to be not as sensitive.  Cooper et al (2002) attained fair agreement between a 
physician and dietitian (weighted kappa = 0.60)20. Visser et al (1999) investigated the 
reliability of the 7-point SGA administered by nursing staff on a small number of dialysis 
patients indicating fair inter-rater reliability (ICC=0.72)27 (Table 4).  Of the scored tools, the 
DMS, inter-rater reliability was good, with a kappa of 0.83 investigated on approximately 30% 
of the sample21. Satisfactory internal reliability of the PG-SGA components was determined 
by -Cronbach coefficient of 0.7318.
Discussion 
SGA is a core assessment tool evidenced by the volume of studies utilising SGA.   
Modifications of the SGA present in the CKD literature include tools that expand the scale of 
the SGA to a larger number of categories (4-point30, 7-point33), allow retrospective 
assessment31, provide a continuous score for components of the SGA18, 21 and incorporate 
objective measures28. SGA along with modified versions have shown clinical and/or 
predictive validity in CKD for both dialysis and non-dialysis populations4, 19, 28, 33-35.
When considering which tool is best to apply, it is important to consider the purpose of the 
nutrition assessment. Tools displaying diagnostic evidence indicate the ability to distinguish 
between other known measures of nutrition status, by clinical and/or criterion validity.  
Prognostic evidence refers to the ability of the tool to predict negative outcomes, such as 
morbidity and mortality, achieved via predictive validity (Table 3 and 4).   
 
Presence of malnutrition: As a prognostic and diagnostic tool, SGA has level II and III-1 
evidence, respectively.  Merging the SGA groups representing “malnourished” (B & C, or <5 
on 7-point or >2 on 4 point scales) appears adequate for clinical and predictive validity, with 
reasonable reliability (Table 4).  Using the scored tools, an MIS >8 appears to predict greater 
morbidity and mortality over 12 months 34, and PG score >9 has good reliability with SGA B 
18.
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By definition, the SGA in its original and modified categorical form (ABC, 4 or 7-point) rank 
nutrition status on an ordinal scale.  This means the rating is given relative to the distribution 
of nutrition status and cannot be assigned a number on a scale, as nutrition status may not be 
of equal value across the rating spectrum.  In all studies, the 7-point SGA, has been treated 
as an interval or continuous score27, 32, 33, 35 (Table 4).  Therefore, relative validity and 
reliability results are based on the assumption that the 7-point scale of the SGA is directly 
linear (interval), which is debateable.  Jones et al (2004) investigated the criterion validity of 7-
point SGA against a composite nutrition score, containing a variety of measures, including the 
original SGA32. Although statistically there appeared to be agreement, the composite score 
distribution between the 7 categories had a large overlap, and non-systematic distribution of 
scores, particularly over ratings 4 to 6 (representing the spectrum of moderate malnutrition) 
therefore the 7-point SGA did not appear linear with this score as the measure of nutrition 
status. 
 
Monitoring nutrition status over time It appears tools providing a continuous score, such 
as the PG-SGA, DMS and MIS have added merit for use in the clinical setting to monitor 
small changes in nutrition status over time, all appear to have clinical validity to key nutrition-
related variables, and reach Level III-2 evidence18, 21. The MIS shows promise as a potential 
predictor of outcome and indicate the degree of Malnutrition Inflammation Cachexia 
Syndrome34. Similarly, small changes in PG-SGA score has previously reflected important 
clinical changes, such as quality of life in oncology36 and length of hospitalisation for general 
medical patients37. The recent study in HD patients indicates the scored PG-SGA may have 
similar merit for use in CKD as it has for oncology patients18. Tools that monitor nutrition 
status on a continuous scale are also beneficial in research, with less reliance on subjectivity, 
and provide greater statistical power than a categorical rating of nutrition status (Table 1).  
However, the linearity of these scored tools has yet to be confirmed, and may have similar 
issues as stated for the 7-point SGA.   
 
Conclusion  
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SGA (A vs. B & C) is a valid method for assessing the presence of malnutrition for diagnostic 
and prognostic purposes.  Continuous scores may improve the clinician’s ability to assess 
small changes in nutrition status, as an ideal nutritional marker should reliably measure 
change in nutrition status, not just predict clinically important outcomes.  In combination, 
these tools can provide a comprehensive assessment for both clinical and research settings.  
 
Recommendations for future research: Future validation studies need to focus on how 
change in nutrition status can be adequately measured. Longitudinal assessments of 
nutrition status are necessary to determine most appropriate tool for use in CKD to measure 
nutrition status prospectively.     
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Table 1: Prevalence of malnutrition by SGA tool and administrator in CKD 
 
Author 
Year 
Rating scale Country Population Administrator Definition of 
Malnutrition 
Prevalence of 
malnutrition 
Fenton 198738 A,B,C Canada 118 PD  Physician or 
nurse 
SGA B or C 23% 
 
Young 199139 A,B,C & obj Europe, US 224 PD  Physician SGA B or C 41% 
Enia 199324 A,B,C Italy 36 HD; 23PD Physician SGA B or C 31% 
Jones 199740 A,B,C England 76 PD Not stated SGA B or C 47% 
Julien 200141 A,B,C France 32 HD Nurses SGA B or C 76% 
Lawson 200115 A,B,C Australia 50 HD Dietitian SGA B or C 28% 
Cooper 200216 A,B,C Australia 52 HD; 24 PD 1) Physician & 
2) Dietitian 
SGA B or C 48% 
42% 
Cupisti 200442 A,B,C Italy 70 pre-dialysis Physician SGA B; no C 29% 
Desbrow  200514 A,B,C Australia 60 HD Dietitian SGA B; no C 20% 
Pifer 200229 mSGA A,B,C USA 7719 HD Retrospective SGA B or C 19%  
Churchill 199631 1-7 Canada and 
US  
680 commencing 
PD 
Not stated SGA 1or2=C 
3,4or5 = B 
55% 
Visser 199925 1-7 Netherlands 13 HD, 9PD Nurses  SGA 1or2=C 
3,4or5 = B 
36% 
Jones 200430 1-7 & A,B,C England 72 HD Dietitian SGA B; no C 31% 
Qureshi 199843 1-4 Sweden 128 HD Physician Rating 2 – 4 64%  
Stenvinkel 199928 1-4 Sweden 119 commencing 
dialysis 
Physician Rating 2 – 4 44% 
Stenvinkel 200232 1-4 
 
Sweden 206 commencing 
dialysis 
Not stated Rating 2 – 4 39% 
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Table 2:  Description, advantages and disadvantages of SGA-based nutrition assessment tools 
utilised in CKD. 
 
Tool Method Modification from SGA Advantages Disadvantages 
 
Retrospective 
mSGA 
 
Rating 
A,B,C 
Retrospective ‘self rating’ 
on A, B, C scale 
 
Conducted as a 
survey (self-
report) 
Relys on self-
report and carer’s 
physical 
assessment 
4-point SGA Rating 
1 to 4  
Expands the “B” category to 
two.  Ratings >2 represent 
malnutrition. 
 
May delineate 
poor nutrition 
status 
Similar issues to 
original, difficult 
to note changes 
over time 
7-point SGA Rating 
7 to 1  
Expands the 3 categories of 
the original SGA, to 7 on a 
Likert-type scale.  
May delineate 
levels of 
nutrition status 
May increase 
inter-observer 
variation 
Dialysis 
Malnutrition 
Score (DMS) 
Scored 
7 to 35 
Scores 7 components of 
the SGA as 1 (normal) to 5 
(very severe).  
Scored so less 
subjectivity  
Allocation of 
scores not based 
on evidence 
Malnutrition 
Inflammation 
Score (MIS) 
Scored 
0 to 30 
10 components, the DMS 
with BMI, serum albumin 
and total-iron binding 
capacity, scored according 
to severity 0 (normal) to 3 
(very severe).  
Includes 
objective 
categories - 
less reliance on 
subjectivity 
 
Requires  
biochemistry 
(albumin and iron 
studies), and  
weight/height 
measures for BMI 
Patient-
Generate 
Subjective 
Global 
Assessment 
(PG-SGA) 
Scored 
0 to 35 
and 
A,B,C 
Provides a numerical score, 
dependant on the impact of 
each SGA component on 
nutrition status.   
Patient 
completes 
medical history, 
scored so less 
subjective 
 
May require more 
patient input 
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Table 3: Definition and study design for validity and reliability testing corresponding draft 
NHMRC level of evidence in reference to nutrition assessment tools in CKD
Definition37 Study design and NHMRC level 
of evidence23 
Clinical 
validity
Explores the relationship that exists in 
known parameters associated with 
nutrition status, but not used in the tool. 
Validity is then only established against 
the parameter within that investigation
Cross-sectional comparison with 
reference that is not a gold 
standard, and/or is not blinded
(Level III-2, Diagnosis)
Predictive 
Validity
Explores the correlation with another 
measure assessed in the future (e.g. 
morbidity and mortality)
Prospective, cohort 
(Level II, Prognosis, applies only 
to studies of diagnostic accuracy)
Criterion 
Validity
Evaluates agreement and performance 
(sensitivity/specificity) of the tool, 
against a valid, gold-standard reference 
measure.  
Cross-sectional blinded
comparison in consecutive or 
non-consecutive patients
(Level II or III-1, Diagnosis)
Inter-rater 
Reliability
Tool can provide good agreement 
between users
Cross-sectional 
Intra-rater 
Reliability
Tool is reproducible aft r test-retest 
assessment
Test-Retest
Internal
Reliability
An assessment of the correlation across 
items within the assessment tool
Cross-sectional 
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Table 4: Validation studies for SGA-derived tools in CKD
Tool Studies included
Author, year, study type (sample)
Clinical
Validity
Predictive
Validity
Criterion
Validity
Reliability Design comments
SGA Enia 1993 Clinical validity (36HD; 23PD)
Lawson 2001 Clinical and predictive
validity 50 CKD (Pre-dialysis)
Cooper 2002 Criterion validity and
reliability (24PD; 52HD)
Albumin, BIA,
(p<0.001)
MAMC, % BF,
nPCR (p<0.05);
Fat-free mass
Mortality/Morbidity
(12 months)
Not established
(Nitrogen Index
<85%= malnutrition)
Inter-observer
reliability Moderate
(weighted k=0.60)
Clinical and criterion validity: blinded
to objective results
Criterion validity: Question Choice of
gold-standard cut-off
Retrospective mSGA Pifer 2002 Predictive (7719 HD) Mortality (6 months) Question face validity
@ death risk for B
7-point SGA scale Chruchill 1996 Clinical and Predictive
validity (680 starting PD)
Visser 1999 Clinical validity and
Reliability 22 Dx (13HD; 9PD)
Jones 2004 Criterion validity (72 HD)
Rating <5: Albumin
1-7
BMI, MAMC, %BF
Mortality/Morbidity
(2-3 years)
Composite nutrition
score (incl SGA,
BMI, TSF, MAMC,
Alb)
Inter-observer
ICC=0.72
Intra-observer
ICC=0.88
Interpreted 7-point SGA as interval
Reliability on small sample (n=16)
Criterion Validity: Large overlap
scores between groups indicate lack
of linearity.
Dialysis Malnutrition
Score
Kalantar-Zadah 1999 Clinical validity and
Reliability (41 HD)
MIS Alb, Cr, BUN,
Iron, Chol, MAMC
(p<0.001)
Inter-observer
K=0.83
No report on “risk” score or
malnutrition cut-off, or number that
refused study.
Reliability on small sample (n=13)
Malnutition
Inflammation Score
Kalantar-Zadah 2001 Clinical and
Predictive validity (83 HD)
Kalantar-Zadah 2004 Clinical and
Predictive validity (378 HD)
Albumin, CRP, Cr,
Hct
IL-6
Morbidity/Mortality
(12 months)
MIS appears to be a “risk
assessment/ outcome predictor” MIS
>8 = high risk
Advantageous to predict outcome
over SGA and DMS
Patient-Generated
Subjective Global
Assessment
Desbrow 2005 Clinical and Criterion
validity and Reliability (60 HD)
Albumin >9 SGA
PG score F9 good
reliability to SGAB:
83% sens, 92%
spec;
Internal Reliability
-coefficient 0.73
NHMRC III-I
Nature of the gold-standard did not
allow ‘blinding’ of the SGA to PG-
SGA
SGA Subjective Global Assessment ; PG-SGA Patient-Generated Subjective Global Assessment ; DMS Dialysis Malnutrition Score ; MIS Malnutrition Inflammation Score
HD Haemodialysis, PD Peritoneal Dialysis, Pre-Dx Pre-Dialysis,
Alb Albumin, nPCR normalised Protein Catabolic Rate, BIA Bio-imedence Phase angle
MAMC Mid-arm muscle circumference, BF Body Fat, TSF Tricep Skin-fold, FFM Fat Free Mass
Cox PHM Cox Proportional Hazards Model, MW Mann-Whitney, MV Multivariate, ICC Interclass correlation
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